Group 1 - The core business of the company is the research, production, and sales of rehabilitation medical devices, with a wide range of products across 10 categories and over 1,000 products [2] - The company has received multiple awards for its projects, including first prizes for various rehabilitation technology initiatives from different medical and scientific associations [2] - As of the first quarter of 2025, the company reported a revenue of 186 million yuan, a year-on-year increase of 10.02%, while net profit decreased by 41.26% to 22.95 million yuan [3] Group 2 - The company's current rolling price-to-earnings (PE) ratio is 109.54, significantly higher than the industry average of 59.32 and the median of 39.97 [3] - The total market capitalization of the company is 9.51 billion yuan [3] - As of the first quarter of 2025, six institutions hold shares in the company, with a total of 634,800 shares valued at 2.8 million yuan [1]